Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Biotronik offers remote, wireless cardiac patient management solution

Biotronik : 19 June, 2008  (New Product)
Biotronik has launched the Lumax 540 series that includes implantable cardioverter defibrillators (ICDs) and a cardiac resynchronization therapy defibrillator (CRT-D), has many industry-leading features to save and enhance patients' lives.
This together with Biotronik Home Monitoring enables continuous automatic daily data transmission of the patient's cardiovascular status. The information is available to the physicians online allowing them to continuously check their patients' cardiac and device status.

Lumax 540 has a range of features that allow physicians to tailor the treatment to our individual patients. Coupled with the Biotronik Home Monitoring technologies, we are able to access patient data online anywhere in the world,' said professor Panos Vardas, Cardiology Department, University Hospital, Heraklion, Crete, Greece.

The Lumax 540 series has a unique set of state-of-the-art features to ensure that patients receive the appropriate therapy adapted to their individual needs while maintaining optimal safety. SelectSense has various presettings to adapt sensing characteristics to individual patient needs to ensure accurate arrhythmia detection.

The Defibrillation Threshold Manager ensures that life-saving shock therapy is delivered successfully. In addition, the Automatic Threshold Monitor performs daily threshold measurements. The Heart Failure Monitor detects changes in heart failure conditions with an extensive range of clinical predictors. A comprehensive set of diagnostic capabilities included in the Lumax 540 devices help physicians with the identification of clinically relevant atrial fibrillation and the early detection of worsening heart failure status.

Biotronik 's extensive engineering research has produced industry-leading batteries which extend the life of the Lumax 540 devices up to 10 years.

'Patients could benefit from this extended battery life due to the need for fewer device replacements over time, thereby improving quality of life and at the same time helping to reduce healthcare costs. In fact, we are so confident in the advantages of our new battery technology, Biotronik will further extend our warranty for our Lumax 540 ICDs', commented Marlou Janssen, vice president global marketing and sales, Cardiac Rhythm Management, Biotronik. 'With the Lumax 540 series Biotronik has demonstrated its commitment to patients by developing the highest quality devices that offer daily protection with optimal therapy delivery for an improved quality of life and to save patients' lives.'

The number of patients with cardiac devices who require follow-up has increased dramatically and is putting clinics under considerable pressures to meet these needs. The innovative set of functionalities of the Lumax 540 series help physicians efficiently and easily automate the in-office follow up of patients with Biotronik devices.

For the first time all essential follow up data are ready for review, print-out and automatic data storage within 20 seconds after device interrogation. The same data is also available to the physician via the Biotronik Home Monitoring technology for daily automatic event detection and on-demand online patient status reviews.

The Lumax 540 devices offer the combination of advanced tachycardia therapy management, diagnostic capabilities and remote monitoring technologies which support physicians in creating efficient care pathways for their patients with cardiac devices and further improve patient care.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo